Topic

Receptor ligands Steady

479 applications whose title mentions it. Its share of new filings over the last two years is 2% above the four years before.

Allowance rate

59%

−16 pts vs the USPTO 456 decided

Months to first action

16.6 mo

−2.0 vs the USPTO

Applications

479.0

in the record

Allowed

270.0

186 abandoned

Filings by year

How often the topic was filed

The most recent years are still filling in.

Where it is examined

Domains and art units

CPC subclasses

C07D242 apps

A61K140 apps

C07K42 apps

C07C23 apps

A61P11 apps

G01N8 apps

Art units

162469 apps

162568 apps

162666 apps

162244 apps

162128 apps

162722 apps

Examiners

Who examines it, and how it fares with each

Emily A Bernhardt16 apps

56%

Kristin Ann Vajda15 apps

67%

Docket Central13 apps

n/a

Matthew P Coughlin13 apps

77%

Jeanette M Lieb12 apps

58%

Niloofar Rahmani12 apps

58%

Rei Tsang Shiao12 apps

75%

Yong Liang Chu10 apps

60%

Bars show the share of decided applications that were allowed.

Unlock the examiners behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who files it

Companies and institutions

AbbVie Inc.37 apps

95%

IPSEN PHARMA S.A.S.21 apps

37%

GRUENENTHAL GMBH19 apps

68%

BRISTOL-MYERS SQUIBB COMPANY13 apps

62%

NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT11 apps

64%

LABORATORIOS DEL DR. ESTEVE, S.A.10 apps

50%

Bars show the share of decided applications that were allowed.

Unlock the filers behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Who represents them

Law firms and agents

ABBVIE INC.35 apps

100%

CROWELL & MORING LLP22 apps

73%

HENRY HADAD18 apps

61%

MERCK15 apps

67%

PATENT DEPT.13 apps

46%

GOODWIN PROCTER LLP12 apps

82%

Bars show the share of decided applications that were allowed.

Unlock the firms behind this topicIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Applications

Recent applications on this topic

Application	Title	Filed	Status	Rejections	RCEs	To 1st action
19626047	LIVER-SPECIFIC ASIALOGLYCOPROTEIN RECEPTOR TARGETING LIGANDS, CONJUGATES COMPRISING…	2026-09-21	Pending	0	0	n/a
19621544	SIGMA-2 RECEPTOR (TMEM97) LIGANDS FOR OCULAR HEALING	2026-09-04	Pending	0	0	n/a
19618496	UROKINASE PLASMINOGEN ACTIVATOR SURFACE RECEPTOR (UPAR) LIGANDS FOR DIAGNOSTIC OR T…	2026-08-26	Pending	0	0	n/a
15612108	Method and apparatus for adaptive signal processing	2012-01-10	Allowed	1	0	12.0 mo
15371965	Composition and method for controlled release	2015-02-11	Abandoned	4	1	23.0 mo
15208154	Distributed ledger transaction verification	2018-03-12	Allowed	3	0	20.0 mo
15773028	Thermal management of battery assemblies	2021-04-13	Pending	2	1	17.0 mo
15634229	Machine learning model for anomaly detection	2012-05-14	Allowed	1	0	14.0 mo
15604779	Wireless power transfer coil arrangement	2015-06-15	Abandoned	4	1	25.0 mo
15187185	Catalyst for selective hydrogenation	2018-07-16	Allowed	3	0	22.0 mo

Unlock every application on this topic, with its timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in